Literature DB >> 29450724

Chromaffin cell biology: inferences from The Cancer Genome Atlas.

Lauren Fishbein1, Matthew D Wilkerson2.   

Abstract

Pheochromocytomas and paragangliomas (PCC/PGLs) are rare neuroendocrine tumors that are unusually diverse in metabolic profiles, in classes of molecular alterations and across a large number of altered genes. The Cancer Genome Atlas (TCGA) comprehensively profiled the molecular landscape of PCC/PGLs and identified novel genomic alterations and a new molecular classification of PCC/PGLs. In this review, we discuss the significant clinico-molecular findings of this integrated profiling study. We then review the molecular data of the TCGA cohort centering around known markers of sympathoadrenal cell lineage to better understand chromaffin cell biology. This analysis adds a new layer, that of chromaffin cell type, onto the published molecular classifications and in doing so provides inferences about underlying chromaffin cell biology and diversity.

Entities:  

Keywords:  Chromaffin cell; Genomics; PNMT; Paraganglioma; Pheochromocytoma

Mesh:

Year:  2018        PMID: 29450724     DOI: 10.1007/s00441-018-2795-0

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  27 in total

1.  Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.

Authors:  G Eisenhofer; T-T Huynh; K Pacak; F M Brouwers; M M Walther; W M Linehan; P J Munson; M Mannelli; D S Goldstein; A G Elkahloun
Journal:  Endocr Relat Cancer       Date:  2004-12       Impact factor: 5.678

2.  Identification and purification of an adrenal medullary protein (synexin) that causes calcium-dependent aggregation of isolated chromaffin granules.

Authors:  C E Creutz; C J Pazoles; H B Pollard
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

3.  Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Marcella M Johnson; Shamim Ejaz; Mouhammed Amir Habra; Thereasa Rich; Naifa Busaidy; Gilbert J Cote; Nancy Perrier; Alexandria Phan; Shreyaskumar Patel; Steven Waguespack; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2010-12-29       Impact factor: 5.958

4.  MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.

Authors:  Nelly Burnichon; Alberto Cascón; Francesca Schiavi; Nicole Paes Morales; Iñaki Comino-Méndez; Nasséra Abermil; Lucía Inglada-Pérez; Aguirre A de Cubas; Laurence Amar; Marta Barontini; Sandra Bernaldo de Quirós; Jérôme Bertherat; Yves-Jean Bignon; Marinus J Blok; Sara Bobisse; Salud Borrego; Maurizio Castellano; Philippe Chanson; María-Dolores Chiara; Eleonora P M Corssmit; Mara Giacchè; Ronald R de Krijger; Tonino Ercolino; Xavier Girerd; Encarna B Gómez-García; Alvaro Gómez-Graña; Isabelle Guilhem; Frederik J Hes; Emiliano Honrado; Esther Korpershoek; Jacques W M Lenders; Rocío Letón; Arjen R Mensenkamp; Anna Merlo; Luigi Mori; Arnaud Murat; Peggy Pierre; Pierre-François Plouin; Tamara Prodanov; Miguel Quesada-Charneco; Nan Qin; Elena Rapizzi; Victoria Raymond; Nicole Reisch; Giovanna Roncador; Macarena Ruiz-Ferrer; Frank Schillo; Alexander P A Stegmann; Carlos Suarez; Elisa Taschin; Henri J L M Timmers; Carli M J Tops; Miguel Urioste; Felix Beuschlein; Karel Pacak; Massimo Mannelli; Patricia L M Dahia; Giuseppe Opocher; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo
Journal:  Clin Cancer Res       Date:  2012-03-27       Impact factor: 12.531

5.  Differences in CART expression and cell cycle behavior discriminate sympathetic neuroblast from chromaffin cell lineages in mouse sympathoadrenal cells.

Authors:  Wing Hei Chan; David G Gonsalvez; Heather M Young; E Michelle Southard-Smith; Kylie N Cane; Colin R Anderson
Journal:  Dev Neurobiol       Date:  2015-06-01       Impact factor: 3.964

6.  Novel pheochromocytoma susceptibility loci identified by integrative genomics.

Authors:  Patricia L M Dahia; Ke Hao; John Rogus; Christian Colin; Miguel A G Pujana; Ken Ross; Danielle Magoffin; Neil Aronin; Alberto Cascon; César Y Hayashida; Cheng Li; Sérgio P A Toledo; Charles D Stiles
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.

Authors:  Nelly Burnichon; Laure Vescovo; Laurence Amar; Rossella Libé; Aurélien de Reynies; Annabelle Venisse; Elodie Jouanno; Ingrid Laurendeau; Béatrice Parfait; Jérôme Bertherat; Pierre-François Plouin; Xavier Jeunemaitre; Judith Favier; Anne-Paule Gimenez-Roqueplo
Journal:  Hum Mol Genet       Date:  2011-07-22       Impact factor: 6.150

8.  Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.

Authors:  G Eisenhofer; M M Walther; T T Huynh; S T Li; S R Bornstein; A Vortmeyer; M Mannelli; D S Goldstein; W M Linehan; J W Lenders; K Pacak
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

9.  Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma.

Authors:  R Bílek; L Šafařík; V Ciprová; P Vlcek; L Lisá
Journal:  Physiol Res       Date:  2008-02-13       Impact factor: 1.881

10.  Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.

Authors:  Luis Jaime Castro-Vega; Eric Letouzé; Nelly Burnichon; Alexandre Buffet; Pierre-Hélie Disderot; Emmanuel Khalifa; Céline Loriot; Nabila Elarouci; Aurélie Morin; Mélanie Menara; Charlotte Lepoutre-Lussey; Cécile Badoual; Mathilde Sibony; Bertrand Dousset; Rossella Libé; Franck Zinzindohoue; Pierre François Plouin; Jérôme Bertherat; Laurence Amar; Aurélien de Reyniès; Judith Favier; Anne-Paule Gimenez-Roqueplo
Journal:  Nat Commun       Date:  2015-01-27       Impact factor: 17.694

View more
  8 in total

Review 1.  What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?

Authors:  Thomas G Papathomas; Diederik P D Suurd; Alfred K Lam; Ronald R de Krijger; Karel Pacak; Arthur S Tischler; Menno R Vriens
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

Review 2.  Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.

Authors:  C Christofer Juhlin
Journal:  Endocr Pathol       Date:  2021-03-25       Impact factor: 3.943

3.  A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/- rats.

Authors:  James F Powers; Brent Cochran; James D Baleja; Hadley D Sikes; Andrew D Pattison; Xue Zhang; Inna Lomakin; Annette Shepard-Barry; Karel Pacak; Sun Jin Moon; Troy F Langford; Kassi Taylor Stein; Richard W Tothill; Yingbin Ouyang; Arthur S Tischler
Journal:  Endocr Relat Cancer       Date:  2020-06       Impact factor: 5.678

Review 4.  Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma.

Authors:  Annika M A Berends; Graeme Eisenhofer; Lauren Fishbein; Anouk N A V D Horst-Schrivers; Ido P Kema; Thera P Links; Jacques W M Lenders; Michiel N Kerstens
Journal:  Cancers (Basel)       Date:  2019-08-06       Impact factor: 6.639

5.  Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development.

Authors:  Hermine Mohr; Simone Ballke; Nicole Bechmann; Sebastian Gulde; Jaber Malekzadeh-Najafabadi; Mirko Peitzsch; Vasilis Ntziachristos; Katja Steiger; Tobias Wiedemann; Natalia S Pellegata
Journal:  Cancers (Basel)       Date:  2021-01-02       Impact factor: 6.639

6.  Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma.

Authors:  Luise Eckardt; Maria Prange-Barczynska; Emma J Hodson; James W Fielding; Xiaotong Cheng; Joanna D C C Lima; Samvid Kurlekar; Gillian Douglas; Peter J Ratcliffe; Tammie Bishop
Journal:  Endocr Relat Cancer       Date:  2021-10-18       Impact factor: 5.678

7.  Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications.

Authors:  Jacopo Manso; Loris Bertazza; Susi Barollo; Alberto Mondin; Simona Censi; Sofia Carducci; Alfonso Massimiliano Ferrara; Isabella Merante Boschin; Stefania Zovato; Francesca Schiavi; Michele Gregianin; Gianmaria Pennelli; Maurizio Iacobone; Caterina Mian
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

8.  A Case of 123I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the RET Gene.

Authors:  Haremaru Kubo; Yuya Tsurutani; Takashi Sunouchi; Yoshitomo Hoshino; Rei Hirose; Sho Katsuragawa; Noriko Kimura; Jun Saito; Tetsuo Nishikawa
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.